Startup & VC Daily Briefing · 13 May 2026 · 4 min

$2.7B Deployed: AI Drugs, Defense Autonomy & Crypto Compliance | Ep. 1

Over $2.7B in disclosed funding across ten deals today, headlined by Isomorphic Labs' $2.1B Series B and a wave of institutional capital entering AI drug discovery, autonomous defense, and crypto compliance infrastructure. Founders, investors, and operators — here's what moved the market.

Startup & VC Daily Briefing
Now Playing
$2.7B Deployed: AI Drugs, Defense Autonomy & Crypto Compliance | Ep. 1

Audio is available on Spreaker — see link below.

What's covered

Isomorphic's $2.1B Drug Discovery Bet

Isomorphic Labs just raised two point one billion dollars. That's a Series B.

Listen now →

Havoc $100M — Defense Autonomy Scaling

Elsewhere in the day's activity, defense tech keeps drawing capital. Havoc, an autonomous multi-domain vehicles startup founded in twenty twenty-four, closed a hundred million dollar Series A.

Listen now →

Elliptic $120M — Compliance as Infrastructure

Crypto compliance firm Elliptic raised a hundred and twenty million dollars in a Series D, hitting a six hundred and seventy million dollar valuation. One Peak led the round.

Listen now →

Exaforce, Judgment Labs, Star Catcher

A few other raises worth flagging from today's activity. Exaforce pulled in a hundred and twenty-five million dollars in a Series B for autonomous cybersecurity threat detection, valuing the company at around seven hundred and twenty-five million dollars.

Listen now →

What to Watch Next

Today's total disclosed funding reached two point seven billion dollars across ten deals. The through-line isn't sector diversity.

Listen now →

Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.

More episodes

From Startup & VC Daily Briefing